MicardisPlus®
Sponsors
Boehringer Ingelheim
Conditions
Hypertension
Unknown Phase
Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus
CompletedNCT02242825
Start: 2006-01-31Updated: 2014-09-17
Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure
CompletedNCT02242864
Start: 2006-01-31Updated: 2014-09-17
Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
CompletedNCT02243566
Start: 2006-04-30Updated: 2014-09-18
Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
CompletedNCT02262611
Start: 2003-01-31Updated: 2014-10-13
Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)
CompletedNCT02262637
Start: 2003-09-30Updated: 2014-10-13